Phase 1 Study of PF-08046033 in Advanced Solid Tumors
NCT07519655
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Small-Cell Lung
Esophageal Cancer
Cutaneous Melanoma
Interventions
DRUG:
PF-08046033
Sponsor
Pfizer